Building upon the successes witnessed with other medications like empagliflozin and dapagliflozin, semaglutide became a recent antidiabetic medication with favourable results in patients with heart failure with preserved ejection fraction. The positive effects include reduced patient discomfort and improved physical performance.

Success with Empagliflozin

Diastolic heart failure (HFpEF, heart failure ...